US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 8.800
  • -0.320-3.51%
Close May 9 16:00 ET
74.04MMarket Cap-146666P/E (TTM)

About Serina Therapeutics Company

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Company Profile

SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Websitehttp://serinatherapeutics.com/

Company Executives

  • Name
  • Position
  • Salary
  • Steven Ledger
  • Director and Interim Chief Executive Officer
  • --
  • Dr. Tacey Viegas, PhD
  • Chief Operating Officer and Secretary
  • --
  • Dr. Randall W. Moreadith,M.D.,PhD
  • Chief Scientific Officer
  • --
  • Andrea E. Park
  • Interim Chief Financial Officer and Chief Accounting Officer
  • --
  • Dr. Simba Gill, PhD
  • Chairman of the Board
  • --
  • J. Milton Harris, PhD
  • Independent Director
  • --
  • Dr. Richard Marshall, M.D.
  • Independent Director
  • --
  • Remy Gross
  • Independent Director
  • --
  • Steven M. Mintz
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg